Compare VATE & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VATE | SXTC |
|---|---|---|
| Founded | 1994 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.5M | 92.9M |
| IPO Year | 1996 | 2017 |
| Metric | VATE | SXTC |
|---|---|---|
| Price | $7.86 | $2.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 89.3K | ★ 670.6K |
| Earning Date | 05-14-2026 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,246,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.55 | N/A |
| 52 Week Low | $3.75 | $0.03 |
| 52 Week High | $21.30 | $6.98 |
| Indicator | VATE | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 47.46 |
| Support Level | $6.41 | $1.92 |
| Resistance Level | $8.20 | $2.77 |
| Average True Range (ATR) | 0.42 | 0.34 |
| MACD | 0.07 | -0.09 |
| Stochastic Oscillator | 32.53 | 35.90 |
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.